These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11522489)

  • 1. Determination of the disintegration behavior of magnetically marked tablets.
    Weitschies W; Hartmann V; Grützmann R; Breitkreutz J
    Eur J Pharm Biopharm; 2001 Sep; 52(2):221-6. PubMed ID: 11522489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic Marker Monitoring: An application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms.
    Weitschies W; Kosch O; Mönnikes H; Trahms L
    Adv Drug Deliv Rev; 2005 Jun; 57(8):1210-22. PubMed ID: 15935870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic marker monitoring of disintegrating capsules.
    Weitschies W; Karaus M; Cordini D; Trahms L; Breitkreutz J; Semmler W
    Eur J Pharm Sci; 2001 Jul; 13(4):411-6. PubMed ID: 11408156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of compression forces on tablets disintegration by AC Biosusceptometry.
    Corá LA; Fonseca PR; Américo MF; Oliveira RB; Baffa O; Miranda JR
    Eur J Pharm Biopharm; 2008 May; 69(1):372-9. PubMed ID: 18164605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical review on tablet disintegration.
    Quodbach J; Kleinebudde P
    Pharm Dev Technol; 2016 Sep; 21(6):763-74. PubMed ID: 25975586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Simple and Inexpensive Image Analysis Technique to Study the Effect of Disintegrants Concentration and Diluents Type on Disintegration.
    Berardi A; Bisharat L; Blaibleh A; Pavoni L; Cespi M
    J Pharm Sci; 2018 Oct; 107(10):2643-2652. PubMed ID: 29935295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation strategy towards minimizing viscosity mediated negative food effect on disintegration and dissolution of immediate release tablets.
    Zaheer K; Langguth P
    Drug Dev Ind Pharm; 2018 Mar; 44(3):444-451. PubMed ID: 29098885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of tablet disintegrants: impact of storage conditions and relative tablet density.
    Quodbach J; Kleinebudde P
    Pharm Dev Technol; 2015; 20(6):762-8. PubMed ID: 24848093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of ethanol on superdisintegrants and on tablets disintegration.
    Bisharat L; AlKhatib HS; Muhaissen S; Quodbach J; Blaibleh A; Cespi M; Berardi A
    Eur J Pharm Sci; 2019 Mar; 129():140-147. PubMed ID: 30630089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of co-processed excipients used for direct compression of orally disintegrating tablets (ODT) using novel disintegration apparatus.
    Brniak W; Jachowicz R; Krupa A; Skorka T; Niwinski K
    Pharm Dev Technol; 2013; 18(2):464-74. PubMed ID: 22881600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic classification of tablet disintegrants by water uptake and force development kinetics.
    Quodbach J; Kleinebudde P
    J Pharm Pharmacol; 2014 Oct; 66(10):1429-38. PubMed ID: 24943882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of disintegration properties of orally rapidly disintegrating tablets using a novel disintegration tester.
    Kondo K; Niwa T; Danjo K
    Chem Pharm Bull (Tokyo); 2012; 60(10):1240-8. PubMed ID: 23036967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of Disintegrants and the Disintegration Phenomena.
    Desai PM; Liew CV; Heng PWS
    J Pharm Sci; 2016 Sep; 105(9):2545-2555. PubMed ID: 27506604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitin's Functionality as a Novel Disintegrant: Benchmarking Against Commonly Used Disintegrants in Different Physicochemical Environments.
    Chaheen M; Soulairol I; Bataille B; Yassine A; Belamie E; Sharkawi T
    J Pharm Sci; 2017 Jul; 106(7):1839-1848. PubMed ID: 28392454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disintegration propensity of tablets evaluated by means of disintegrating force kinetics.
    Massimo G; Catellani PL; Santi P; Bettini R; Vaona G; Bonfanti A; Maggi L; Colombo P
    Pharm Dev Technol; 2000; 5(2):163-9. PubMed ID: 10810746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disintegration of magnetic tablets in human stomach evaluated by alternate current biosusceptometry.
    Corá LA; Américo MF; Oliveira RB; Baffa O; Moraes R; Romeiro FG; Miranda JR
    Eur J Pharm Biopharm; 2003 Nov; 56(3):413-20. PubMed ID: 14602185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of mode of incorporation of disintegrants on the characteristics of fluid-bed wet-granulated tablets.
    Khattab I; Menon A; Sakr A
    J Pharm Pharmacol; 1993 Aug; 45(8):687-91. PubMed ID: 7901364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new apparatus for real-time assessment of the particle size distribution of disintegrating tablets.
    Quodbach J; Kleinebudde P
    J Pharm Sci; 2014 Nov; 103(11):3657-3665. PubMed ID: 25223505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing gastrointestinal motility and disintegration profiles of magnetic tablets by a novel magnetic imaging device and gamma scintigraphy.
    Goodman K; Hodges LA; Band J; Stevens HN; Weitschies W; Wilson CG
    Eur J Pharm Biopharm; 2010 Jan; 74(1):84-92. PubMed ID: 19602377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of disintegration of rapidly disintegrating tablets by a visiometric liquid jet-mediated disintegration apparatus.
    Desai PM; Liew CV; Heng PW
    Int J Pharm; 2013 Feb; 442(1-2):65-73. PubMed ID: 22985772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.